ClinicalTrials.gg
RecruitingNCT07619274Updated Nov 5, 2026

Right Ventricular Function and Respiratory Acidosis After Cardiac Surgery

An observational study in Respiratory Acidosis in ICU Patients, Right Ventricular (RV) Dysfunction and Hemodynamic Changes, sponsored by Laval University. Recruiting at 1 site in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-05.

Sponsored by Laval University · Observational

How we know

From the registry’s dates

  • Started Jul 2026; still recruiting 4 months later.
Updated Nov 5, 2026Now RecruitingSite recruiting status changed+3 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
220
Ages
18 Years and older
Sex
All
01

Study summary

Right heart dysfunction remains a frequent cause of morbidity and mortality after cardiac surgery. Respiratory acidosis, particularly when accompanied by hypoxemia, plays a significant role in right heart failure, primarily by increasing right ventricular afterload through pulmonary vasoconstriction and elevated pulmonary arterial pressures. This phenomenon leads to increased right ventricular workload, causing dilation, decreased contractility, and ultimately right heart failure. The study aims to evaluate the effect of respiratory acidosis on right ventricular function after cardiac surgery.

Read the detailed description

Post hoc analysis of data from two separate studies previously approved by the Research Ethics Board NCT05886413 and NCT06826794. A stratification according to respiratory acidosis defined by a pH \<7.35 with PaCO₂ >45mmHg on the first arterial blood gas analysis at the intensive care unit arrival will be done.

02

Conditions studied

  • Respiratory Acidosis in ICU Patients
  • Right Ventricular (RV) Dysfunction
  • Hemodynamic Changes
  • Mechanical Ventilation

Browse trials for

03

In context

Acidosis, Respiratory

22 studies on the registry are indexed under Acidosis, Respiratory; 6 are open to participants now.

Browse Acidosis, Respiratory studies →

Lead sponsor

Laval University is the lead sponsor of 380 studies on the registry; 67 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult patients who underwent cardiac surgery mechanically ventilated in controlled mode, and had an arterial blood gas within the first hour following admission.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Previously included and complete study NCT05886413 or NCT06826794

Exclusion criteria

Exclusion Criteria:

  • Absence of one or more of the following hemodynamic measurements: systolic or diastolic pulmonary artery pressure, central venous pressure, cardiac output
  • Absence of arterial blood gas on arrival to the intensive care unit
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
220 participants (estimated)
Patient registry
No

Groups and cohorts

  • Retrospective cohort

    Completed study. Adult patients who underwent cardiac surgery were included if they were admitted to the intensive care unit immediately after surgery, mechanically ventilated in controlled mode, and had an arterial blood gas within the first hour following admission.

    Other: Not applicable- observational study

  • Prospective cohort

    Completed study. Adult patient included on open-label randomized study, comparing clinician-chosen initial mechanical ventilation parameters to those recommended by an algorithm immediately after ICU admission.

    Other: Not applicable- observational study

Interventions

  • OtherNot applicable- observational study

    No intervention

06

What researchers measure

Primary outcomes

  1. Right ventricular function per central hemodynamic assessment

    Calculation of different predictor: Cardiac index, PAPi (pulmonary artery pulse pressure over central venous pressure) , RVSWI ((mean pulmonary artery pressure- central venous pressure) X stroke volume index X 0.0136) and RV-CPO

    Time frame: At intensive care unit admission - within the first 4 hours

Secondary outcomes

  1. Intensive care unit length of stay

    Intensive care unit admission through Intensive care unit discharge

    Time frame: Up to 28 days

  2. Mechanical ventilation duration

    Time spent with invasive mechanical ventilation between intensive care unit admission and hospital discharge

    Time frame: Day 28

  3. Vasopressor duration

    Duration of vasopressor or inotrope administration

    Time frame: Day 28

  4. Acute renal failure

    Rate of acute renal failure during coronary unit length of stay. Renal failure will be defined according to the usual criteria, i.e., an increase of \>27 umol/L creatinine in 48 hours or 1.5x over the baseline

    Time frame: Day 28

  5. Mortality

    Mortality in intensive care unit

    Time frame: Day 28

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Started Jul 2026 (actual). Primary completion is estimated for Dec 2026, 5 months after the start.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 5, 2026: start May 2026 → Jul 2026, primary completion Aug 2026 → Dec 2026 and completion Oct 2026 → Jun 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
May 8, 2026
First posted
Jun 1, 2026
StartActual
Jul 20, 2026was May 2026
Primary completionEst.
Dec 2026was Aug 2026
CompletionEst.
Jun 2027was Oct 2026
Last update
Nov 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Nov 5, 2026
Sites
Institut universitaire de cardiologie et de pneumologie de Quebec - Universite Laval is now Recruiting
Nov 5, 2026
Start date
May 2026→Jul 20, 2026 (actual)
Nov 5, 2026
Primary completion
Aug 2026→Dec 2026
Nov 5, 2026
Study completion
Oct 2026→Jun 2027
Nov 5, 2026
Site contacts
Changed at 1 site. See the sites
Show the site
  • Institut universitaire de cardiologie et de pneumologie de Quebec - Universite Laval · Québec, CanadaContact added e•••@ulaval.ca · •••8711
Nov 5, 2026
Show all 1 update
  1. Nov 5, 2026
    Not yet recruiting→Recruiting
    Institut universitaire de cardiologie et de pneumologie de Quebec - Universite Laval is now Recruiting
    Start date May 2026→Jul 20, 2026 (now actual)
    Primary completion Aug 2026→Dec 2026
    Study completion Oct 2026→Jun 2027
    Site contacts Changed at 1 site. See the sites
    Show the site
    • Institut universitaire de cardiologie et de pneumologie de Quebec - Universite Laval · Québec, CanadaContact added e•••@ulaval.ca · •••8711
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07619274
Lead sponsor
Laval University
Responsible party
François Lellouche (Co-Investigator, Laval University) — Principal investigator
First posted
Jun 1, 2026
Start date
Jul 20, 2026
Primary completion
Dec 2026 (estimated)
Completion
Jun 2027 (estimated)
Last update
Nov 5, 2026

Study contacts

Etienne Couture
Contact
etienne.couture.3@ulaval.ca
1-418-656-8711

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion